Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Caplyta alternatives?How much is caplyta without insurance?Onpattro eu approval?Production on onpattro?Onpattro formulation?
See the DrugPatentWatch profile for Sublocade
Sublocade (buprenorphine extended-release injection) received FDA approval on October 26, 2017 [1].
This date refers to when the FDA approved Sublocade for marketing, not when it first entered clinical practice or when later dosage forms/label updates were approved [1].
The source provided here gives the initial FDA approval date; it does not list subsequent approval dates for label supplements or new formulations. If you need a later timeline, you can use the same FDA-regulatory tracking approach tied to Sublocade’s approval history [1].
[1] https://www.drugs.com/history/sublocade.html
Other Questions About Sublocade :